Cun HT - Search Results

1

Risk of Peritoneal Carcinomatosis After Risk-Reducing Salpingo-Oophorectomy: A Systematic Review and Individual Patient Data Meta-Analysis.

Steenbeek MP, van Bommel MHD, Bulten J, Hulsmann JA, Bogaerts J, Garcia C, Cun HT, Lu KH, van Beekhuizen HJ, Minig L, Gaarenstroom KN, Nobbenhuis M, Krajc M, Rudaitis V, Norquist BM, Swisher EM, Mourits MJE, Massuger LFAG, Hoogerbrugge N, Hermens RPMG, IntHout J, de Hullu JA. Steenbeek MP, et al. Among authors: cun ht. J Clin Oncol. 2022 Jun 10;40(17):1879-1891. doi: 10.1200/JCO.21.02016. Epub 2022 Mar 18. J Clin Oncol. 2022. PMID: 35302882 Free PMC article.

2

Unanswered Questions in High-Risk Women Undergoing Risk-Reducing Salpingo-oophorectomy.

Cun HT, Lu KH. Cun HT, et al. Obstet Gynecol. 2020 Mar;135(3):495-497. doi: 10.1097/AOG.0000000000003733. Obstet Gynecol. 2020. PMID: 32028509 No abstract available.

3

Targeting Dopamine Receptor D2 by Imipridone Suppresses Uterine Serous Cancer Malignant Phenotype.

Hu W, Zhang L, Ferri-Borgogno S, Kwan SY, Lewis KE, Cun HT, Yeung TL, Soliman PT, Tarapore RS, Allen JE, Guan X, Lu KH, Mok SC, Au-Yeung CL. Hu W, et al. Among authors: cun ht. Cancers (Basel). 2020 Aug 27;12(9):2436. doi: 10.3390/cancers12092436. Cancers (Basel). 2020. PMID: 32867127 Free PMC article.

4

Correction: Hu, W., et al. Targeting Dopamine Receptor D2 by Imipridone Suppresses Uterine Serous Cancer Malignant Phenotype. Cancers 2020, 12, 2436.

Hu W, Zhang L, Ferri-Borgogno S, Kwan SY, Lewis KE, Cun HT, Yeung TL, Soliman PT, Tarapore RS, Allen JE, Guan X, Lu KH, Mok SC, Au-Yeung CL. Hu W, et al. Among authors: cun ht. Cancers (Basel). 2021 Feb 4;13(4):623. doi: 10.3390/cancers13040623. Cancers (Basel). 2021. PMID: 33557446 Free PMC article.

5

Isolated vaginal recurrence in women with stage I endometrial cancer.

Rios-Doria E, Cun HT, Filippova OT, Mueller JJ, Alektiar KM, Ellenson LH, Makker V, Lakhman Y, Leitao MM Jr, Jhingran A, Soliman PT, Abu-Rustum NR. Rios-Doria E, et al. Among authors: cun ht. Gynecol Oncol. 2023 Dec;179:9-15. doi: 10.1016/j.ygyno.2023.10.011. Epub 2023 Oct 20. Gynecol Oncol. 2023. PMID: 37864854

6

Exceptional Response to Pembrolizumab for Treatment of Metastatic Chemorefractory Endometrial Carcinoma in a Patient with Lynch Syndrome: A Case Report.

Batman S, Rauh-Hain JA, Grinsfelder MO, Harrison R, Avila M, Cun H, How JA, Tandon N, Wang X, Hinchcliff E, Jazaeri AA, Schmeler KM. Batman S, et al. Case Rep Oncol. 2023 Apr 27;16(1):273-278. doi: 10.1159/000530154. eCollection 2023 Jan-Dec. Case Rep Oncol. 2023. PMID: 37123608 Free PMC article.

7

Comprehensive molecular characterization of early stage grade 3 endometrioid endometrial adenocarcinoma.

Cun HT, Bernard L, Lande KT, Lawson BC, Nesbakken AJ, Davidson B, Lindemann K, Fellman B, Sørlie T, Soliman PT, Eriksson AGZ. Cun HT, et al. Gynecol Oncol. 2024 Oct;189:138-145. doi: 10.1016/j.ygyno.2024.07.677. Epub 2024 Aug 9. Gynecol Oncol. 2024. PMID: 39126895 Free article.

8

Comprehensive Review of Uterine Leiomyosarcoma: Pathogenesis, Diagnosis, Prognosis, and Targeted Therapy.

Yang Q, Madueke-Laveaux OS, Cun H, Wlodarczyk M, Garcia N, Carvalho KC, Al-Hendy A. Yang Q, et al. Cells. 2024 Jun 26;13(13):1106. doi: 10.3390/cells13131106. Cells. 2024. PMID: 38994959 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Search Page

Filters